Comera Life Sciences Holdings IncOTCQB:CMRA
- LAST PRICE0.0410
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0410
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | CMRA |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Comera Life Sciences Holdings Inc | 1.3M | -0.1x | --- |
AVAX Technologies Inc | 14.3K | 0.0x | --- |
Peak Bio Inc | 117.7K | 0.0x | --- |
Corix Bioscience Inc | 20.0 | 0.0x | --- |
Viropro Inc | 1.2K | 0.0x | --- |
Applied Biosciences Corp | 4.4K | 0.0x | --- |
Company Information
Comera Life Sciences Holdings, Inc. is a pre-clinical biotechnology company. The Company applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The Company is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. Its product programs include CLS-001, a preclinical stage bio better for Crohn’s and Ulcerative Colitis disease, and CLS-002, a preclinical stage bio better for various oncology indications. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.
Contact Information
- Headquarters
- 12 Gill Street, Suite 4650WOBURN, MA, United States 01801
- Phone
- 617-871-2101
- Fax
- 561-694-1639
Executives
- Chief Executive Officer, Chief Financial Officer
- Michael Campbell
- Chief Business Officer
- Janice Mccourt
- Independent Director
- Roopom Banerjee
- Independent Director
- Kirsten Flowers
- Independent Director
- Stuart Randle
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3M |
|---|---|
Revenue (TTM) | $1.0M |
Shares Outstanding | 30.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.21 |
EPS | $-0.49 |
Book Value | $-0.10 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -914.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
